Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.
McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.
ASCO Foundation Raised $200,000 In Its First Year.
ASCO Selects Three Cities For Quality Of Care Study.
Early Detection Network Completes Initial Funding From NCI.
FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.
Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.
One Health Plan, Genzyme Agree On Genetic Testing.
ECOG To Cease Participation In Melanoma Vaccine Study.
Vysis, Genentech In Agreement On HER-2 Breast Cancer Test.
Myriad Wins Patent For p10 Tumor Suppressor Gene.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- Scaling excellence: How City of Hope is transforming cancer care delivery
